Sakar Healthcare has partnered with Zydus Lifesciences to supply oncology products in GCC countries and other emerging markets. This marks the company's 40th global agreement in the anti-cancer segment. Sakar Healthcare is expanding its international oncology business and strengthening its presence in emerging markets. The company is also progressing with regulatory filings and approvals in highly regulated markets.
RSS News
Economic times
0 thoughts on “Sakar Healthcare partners with Zydus Lifesciences for GCC Markets”
Leave a Reply
Your email address will not be published. Required fields are marked *
